| Combination antiretroviral therapy. | |
| | |
MedLine Citation:
|
PMID: 21434758 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Combination antiretroviral therapy (cART) was one of the greatest achievements in medicine in the twentieth century. It has rapidly evolved during the last 10 years from suboptimal monotherapy to an effective triple therapy that can change the natural history of HIV-1 infection from a deadly disease to a chronic, manageable condition. However, a dreadful toll of long-term toxicity was experienced by HIV-1-infected patients in the cART era. We have recently entered in a new phase of cART, in which efficacy has been increased and toxicity minimized. Currently, the greatest challenge is to make cART available to everybody who needs it with the future prospects of HIV-1 eradication. |
| | |
Authors:
|
Pere Domingo; Francesc Vidal |
Related Documents
:
|
9405768 - Surgical management of neonatal hydrocephalus. 1826028 - Gastroschisis, malrotation, and chylous ascites. 22611268 - Pharmacy practice department chairs' perspectives on part-time faculty members. 21277078 - Toxicities of targeted therapy and their management in kidney cancer. 20441578 - Social determinants of prescribed and non-prescribed medicine use. 17260908 - Top 10 questions to ask when looking at an ehr license agreement. |
Publication Detail:
|
Type: Editorial Date: 2011-03-24 |
Journal Detail:
|
Title: Expert opinion on pharmacotherapy Volume: 12 ISSN: 1744-7666 ISO Abbreviation: Expert Opin Pharmacother Publication Date: 2011 May |
Date Detail:
|
Created Date: 2011-04-08 Completed Date: 2011-12-12 Revised Date: 2011-12-19 |
Medline Journal Info:
|
Nlm Unique ID: 100897346 Medline TA: Expert Opin Pharmacother Country: England |
Other Details:
|
Languages: eng Pagination: 995-8 Citation Subset: IM |
Copyright Information:
|
© 2011 Informa UK, Ltd |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Anti-HIV Agents
/
adverse effects*,
therapeutic use* Antiretroviral Therapy, Highly Active* / adverse effects HIV Infections / drug therapy* HIV-1* Humans Treatment Outcome |
| Chemical | |
Reg. No./Substance:
|
0/Anti-HIV Agents |
| Comments/Corrections | |
Comment In:
|
Expert Opin Pharmacother. 2011 Dec;12(17):2763-4
[PMID:
21895542
]
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Effects of adalimumab therapy on disease activity and interferon-?-mediated biochemical pathways in ...
Next Document: Social and behavioural determinants of alcohol consumption.